Etanercept and adalimumab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons leading to discontinuation of the treatment

    Activity: Talk or presentationConference presentation

    Description

    Contributors: Levälampi T, Korpela M, Vuolteenaho K, Moilanen E
    Period31 Jan 2008
    Event title32nd Scandinavian Congress of Rheumatology
    Event typeOther
    Degree of RecognitionInternational